Cardiac Dysfunction in Patients with Fatty Liver Disease

RecruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

July 15, 2023

Primary Completion Date

August 15, 2027

Study Completion Date

November 15, 2027

Conditions
NAFLDCardiac DiseaseFatty LiverMASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
Interventions
DIAGNOSTIC_TEST

Echocardiographic assessment

M mode, cross sectional and pulsed wave Doppler Echocardiographic examinations will be performed using a with a 2.5 MHz wide angle phased array transducer. Patients will be laid in left lateral position and examined in standard parasternal long and short axis and apical views. Short axis recordings will be performed at the level of the papillary muscles. M mode tracings will be recorded at the level of the papillary muscles and the aortic valves, with 2 -D guidance. LV wall thickness and cavity diameters will be measured by M mode, through the largest diameter of the ventricle, if possible, both in diastole and systole. Using the cross-sectional images as a guide, the M mode tracing of the left ventricle will obtained to calculate measurements according to the recommendations of American Society of Echocardiography.

Trial Locations (1)

160012

RECRUITING

Dr. Madhumita Premkumar, Chandigarh

All Listed Sponsors
lead

Post Graduate Institute of Medical Education and Research, Chandigarh

OTHER